These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 20036050)
1. HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells. Lee D; Kwon JH; Kim EH; Kim ES; Choi KY Cancer Lett; 2010 Jun; 292(1):125-32. PubMed ID: 20036050 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Koivusalo R; Krausz E; Helenius H; Hietanen S Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516 [TBL] [Abstract][Full Text] [Related]
3. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633 [TBL] [Abstract][Full Text] [Related]
4. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Butz K; Ristriani T; Hengstermann A; Denk C; Scheffner M; Hoppe-Seyler F Oncogene; 2003 Sep; 22(38):5938-45. PubMed ID: 12955072 [TBL] [Abstract][Full Text] [Related]
5. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
7. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells. Bañuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435 [TBL] [Abstract][Full Text] [Related]
8. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Pim D; Massimi P; Banks L Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760 [TBL] [Abstract][Full Text] [Related]
9. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. Desaintes C; Demeret C; Goyat S; Yaniv M; Thierry F EMBO J; 1997 Feb; 16(3):504-14. PubMed ID: 9034333 [TBL] [Abstract][Full Text] [Related]
10. Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids. Isaacs JS; Chen P; Garza A; Hansen MF; Barrett JC; Weissman BE Oncogene; 1997 Apr; 14(14):1669-78. PubMed ID: 9135068 [TBL] [Abstract][Full Text] [Related]
11. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. Stewart D; Ghosh A; Matlashewski G J Virol; 2005 Jul; 79(14):8773-83. PubMed ID: 15994771 [TBL] [Abstract][Full Text] [Related]
12. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Thomas M; Matlashewski G; Pim D; Banks L Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365 [TBL] [Abstract][Full Text] [Related]
14. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691 [TBL] [Abstract][Full Text] [Related]
15. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M; Milner J Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116 [TBL] [Abstract][Full Text] [Related]
16. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218 [TBL] [Abstract][Full Text] [Related]
18. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367 [TBL] [Abstract][Full Text] [Related]
19. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033 [TBL] [Abstract][Full Text] [Related]
20. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6. Molinari M; Milner J Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]